You've been vaccinated; can you now safely see your friends and family? New research hints that vaccinated people may be less likely to transmit the coronavirus, but they are not 100% in the clear.
L’expertise universitaire, l’exigence journalistique
Articles sur Moderna vaccine
Ensemble des articles
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
The COVID-19 vaccine rollout has fallen far short of President Trump's promises. President Biden says he can fix that. Can he?
Two pharmacists involved in COVID-19 vaccine preparation explain the role pharmacists are poised to play in expanding vaccine access.
Rollout of COVID-19 vaccines has begun. But getting the jab doesn't mean abandoning masks, distancing and handwashing. Here's why the current preventive measures must continue post-vaccine.
Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the UK. This probably isn't a big problem, but the data isn't in yet.
Experts from across The Conversation assess the work that's helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Here's what we still need to find out before we can know when we'll be able to return to our pre-coronavirus ways.
We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a summary of their suggestions.
COVID-19 vaccines are at risk of being undermined by vaccine hesitancy. Pharma must take steps to ensure transparency in data monitoring committees and trial data to build public trust in vaccines.
Les contributeurs les plus fréquents
-
Director, Center for Public Interest Communications, University of Florida
-
John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Assistant Professor of Political Science, Oklahoma State University
-
Postdoctoral research associate, University of Florida
-
Associate Director of Microbiology, University of California San Diego
-
Director of Skills Education and Clinical Assistant Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
-
Senior Research Fellow and Lecturer in Mathematical Modelling, UCL
-
Professor of medicine, epidemiology & biostatistics, and philosophy, Western University
-
Instructor in Biology, University of Winnipeg
-
Professor, Biology, York University, Canada
-
Professor of Law, Public Health Sciences, and Public Policy, University of Virginia
-
Assistant Professor of Biology, Penn State
-
Professor and Canada Research Chair in Industrial and Applied Mathematics, York University, Canada
